LAMEA Nifedipine Market Size & Outlook, 2022-2030

LAMEA Nifedipine Market Size, Share & Trends Analysis Report By Type (Nifedipine Controlled-Release Tablets, Nifedipine Extended Action Tablets), By Application (Primary Pulmonary Hypertension, Heart Failure, Raynaud’s Syndrome, Cephalalgia, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region (North America, Asia-Pacific, Europe, Latin America, The Middle East and Africa) and By Country(Brazil, Mexico, Argentina, Chile, Colombia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of LAMEA) Forecasts, 2022-2030

Report Code: SRPH3138DR

Last Updated : Nov, 2022

Pages : 80

Author : Mitiksha Koul

Format : PDF, Excel

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

LAMEA

ESG Trends

LAMEA Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Nifedipine Controlled-Release Tablets
  1. By Value
3. Nifedipine Extended Action Tablets
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Primary Pulmonary Hypertension
  1. By Value
3. Heart Failure
  1. By Value
4. Raynaud’s Syndrome
  1. By Value
5. Cephalalgia
  1. By Value
6. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacies
  1. By Value
3. Retail Pharmacies
  1. By Value
4. Others
  1. By Value
By Region
1. Introduction
  1. Region By Value
2. North America
  1. By Value
3. Asia-Pacific
  1. By Value
4. Europe
  1. By Value
5. Latin America
  1. By Value
6. The Middle East and Africa
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Nifedipine Controlled-Release Tablets
    1. By Value
  3. Nifedipine Extended Action Tablets
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Primary Pulmonary Hypertension
    1. By Value
  3. Heart Failure
    1. By Value
  4. Raynaud’s Syndrome
    1. By Value
  5. Cephalalgia
    1. By Value
  6. Others
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacies
    1. By Value
  3. Retail Pharmacies
    1. By Value
  4. Others
    1. By Value
4. By Region
  1. Introduction
    1. Region By Value
  2. North America
    1. By Value
  3. Asia-Pacific
    1. By Value
  4. Europe
    1. By Value
  5. Latin America
    1. By Value
  6. The Middle East and Africa
    1. By Value
Mexico
Argentina
Chile
Colombia
UAE
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of LAMEA

Competitive Landscape

LAMEA Nifedipine Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Boehringer Ingelheim GmbH
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
AstraZeneca plc
Pfizer Inc.
GlaxoSmithKline plc

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment